Authors:
KOSCIELNY S
TERRIER P
SPIELMANN M
DELARUE JC
Citation: S. Koscielny et al., PROGNOSTIC IMPORTANCE OF LOW C-ERBB2 EXPRESSION IN BREAST-TUMORS, Journal of the National Cancer Institute, 90(9), 1998, pp. 712-712
Authors:
ELIAS D
DEALBUQUERQUE AC
EGGENSPIELER P
PLAUD B
DUCREUX M
SPIELMANN M
THEODORE C
BONVALOT S
LASSER P
Citation: D. Elias et al., RESECTION OF LIVER METASTASES FROM A NONCOLORECTAL PRIMARY - INDICATIONS AND RESULTS BASED ON 147 MONOCENTRIC PATIENTS, Journal of the American College of Surgeons, 187(5), 1998, pp. 487-493
Citation: G. Riou et al., EXPRESSION OF THE APOPTOSIS-RELATED GENES C-MYC, P53 AND BCL2 IN BREAST CARCINOMAS FROM OPERABLE PATIENTS - ONLY BCL2 EXPRESSION IS ASSOCIATED WITH A LOWER RISK OF DEATH, European journal of cancer, 34, 1998, pp. 450-450
Authors:
TUBIANAHULIN M
NAMER M
TUBIANAMATHIEU N
PIOT G
EYMARD JC
BOUGNOUX P
CULINE S
MANSOURI H
BOCCARA C
SPIELMANN M
Citation: M. Tubianahulin et al., ALTERNATING AND SEQUENTIAL SCHEDULES OF TAXOTERE FEC-75 IN THE FIRST LINE TREATMENT OF METASTATIC BREAST-CANCER/, Annals of oncology, 9, 1998, pp. 570-570
Authors:
ABE O
ABE R
ENOMOTO K
KIKUCHI K
KOYAMA H
NOMURA Y
SAKAI K
SUGIMACHI K
TOMINAGA T
UCHINO J
YOSHIDA M
BENRAADT J
VANDEVELDE AO
VANDONGEN JA
VERMORKEN JB
GIOKAS G
LISSAIOS B
HARVEY VJ
HOLDAWAY TM
KAY RG
MASON BH
COATES A
FORBES JF
FOCAN C
LOBELLE JP
GATES GD
POWELL J
DURAND M
MAURIAC L
BARTHOLOMEUS S
PICCART MJ
GELMAN RS
HENDERSON IC
SHAPIRO CL
HANCOCK AK
MASOOD MB
PARKER D
PRICE JJ
JACKSON S
RAGAZ J
DELOZIER T
MACELESECH J
HAYBITTLE JL
BERRY D
BROADWATER G
CIRRINCIONE C
MUSS H
NORTON L
BAUM M
HOUGHTON J
RILEY D
DENT DM
GUDGEON CA
HACKING A
GORDON NH
DAVIS HL
ROMESTAING P
LEHINGUE Y
OWEN JR
MEIER P
HOWELL A
RIBEIRO GC
SWINDELL R
ALBANO J
DEOLIVEIRA CF
GERVASIO H
GORDILHO J
CARSTENSEN B
PALSHOF T
JOHANSEN H
KORZENIOWSKI S
SKOLYSZEWSKI J
PORTNOJ SM
ANDERSEN KW
AXELSSON CK
BLICHERTTOFT M
MOURIDSEN HT
OVERGAARD M
ROSE C
CORCORAN N
TRAMPISCH HJ
COMIS RL
DAVIDSON NE
GRAY R
ROBERT N
TORMEY DC
WOOD W
CHETTY U
FORREST P
JACK W
ROSSBACH J
SYLVESTER RJ
VANDEVELDE CJH
CUNNINGHAM MP
BONNETERRE J
FUMOLEAU P
NAMER M
BASTERT G
RAUSCHECKER H
SAUER R
SAUERBREI W
SCHAUER A
SCHUMACHER M
DESCHRYVER A
BELFIGLIO M
MARI E
NICOLUCCI A
SCORPIGLIONE N
YOSEF HMA
MCARDLE CS
SMITH DC
LARA PC
BOCCARDO F
RUBAGOTTI A
ERAZO A
MEDINA JY
IZUO M
MORISHITA Y
BENTLEY A
DORAN Z
FENTIMAN IS
HAYWARD JL
RUBENS RD
KAUFMANN M
JONAT W
SCHEURLEN H
VONFOURNIER D
FOUNTZILAS G
KLAFSTROM P
BLOMQVIST C
CUZICK J
MARGREITER R
CASTIGLIONE M
CAVILLI F
COLLINS J
FORBES J
GELBER RD
GOLDHIRSCH A
LINDTNER J
PRICE KN
RUDENSTAM CM
SENN HJ
BLISS JM
CHILVERS CED
COOMBES RC
MARTY M
BOROVIK R
BRUFMAN G
HAYAT H
ROBINSON E
WIGLER N
PANNUTI F
TAKASHIMA S
YASUTOMI T
SONOO H
YAMASHITA J
OGAWA M
WELVAART K
HUPPERETS PSGJ
BONTE J
TENGRUP I
TENNVALLNITTBY L
MARTIN P
ROMAIN S
INGLE JN
SUMAN VJ
BUZDAR AU
SMITH T
HAKES T
WITTES R
DELAHUERTA R
SAINZ MG
BONADONNA G
DELVECCHIO M
VALAGUSSA P
VERONESI U
DUBOIS JB
BIANCO AR
LIPPMAN ME
PIERCE LJ
SIMON R
STEINBERG SM
MYLES JD
PATER JL
PRITCHARD KI
ANDERSON S
BROWN A
BRYANT J
COSTANTINO J
DIGNAM J
FISHER B
REDMOND C
WIEAND S
WOLMARK N
JACKSON IM
PALMER MK
BENGTSSON NO
LARSSON LG
LYTHGOE JP
KISSIN M
HANNISDAL E
VARHAUG JE
NISSENMEYER R
BLAMEY RW
MITCHELL AK
ROBERTSON JFR
UEO H
MATHE G
MISSET JL
ABUZAHRA HT
CLARKE EA
MCLAUGHLIN JR
CLARK RM
LEVINE M
MORIMOTO K
SAWA K
TAKATSUKA Y
GUNDERSEN S
HAUERJENSEN M
HOST H
CROSSLEY E
HARRIS A
BEIGHTON A
CLARKE M
COLLINS R
DAVIES C
EVANS V
GODWIN J
GREAVES E
HARWOOD C
JACKSON D
JAMES S
LAU E
MEAD G
NAUGHTEN A
PETO R
TOOTH A
RAMBERT P
ASSELAIN B
SALMON RJ
VILCOQ JR
ARRIAGADA R
HILL C
LAPLANCHE A
LE MG
SPIELMANN M
COCCONI G
DIBLASIO B
CATALANO R
CREECH RH
BROCKSCHMIDT J
COOPER MR
ANDRYSEK O
BARKMANOVA J
FALKSON CI
ABRAHAM M
KLIJN JGM
TREURNIETDONKER AD
VANPUTTEN WLJ
EASTON D
POWLES TJ
GAZET JC
SEMIGLAZOV V
DESHPANDE N
DIMARTINO L
DOUGLAS P
LINDTNER A
NOTTER G
BRYANT AJS
EWING GH
KRUSHENKOSLOSKI JL
GEORGE WD
GOULD A
STEWART HJ
STRONER P
MOLLER TR
RYDEN S
CARSTENSEN J
HATSCHEK T
SODERBERG M
CARPENTER JT
ALBAIN K
CROWLEY J
GREEN S
MARTINO S
OSBORNE CK
RAVDIN PM
RUTQVIST LE
WALLGREN A
HOLM LE
THURLIMANN B
BRENNER H
HERCBERGS A
YOSHIMOTO M
DEBOER G
PATERSON AHG
MEAKIN JW
PANZARELLA T
NAJA A
BAHI J
REID M
SPITTLE M
SENANAYAKE F
BERGH J
HOLMBERG L
SEVELDA P
ZIELINSKY CC
GNANT M
JAKESZ R
BUCHANAN RB
CROSS M
DUNN JA
GILLESPIE WM
KELLY K
MORRISON JM
LITTON A
CHLEBOWSKI RT
BEZWODA WR
CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
Authors:
LLOMBARTCUSSAC A
PIVOT X
RHORALVARADO A
LECESNE A
LECHEVALIER T
TURSZ T
SPIELMANN M
Citation: A. Llombartcussac et al., FIRST-LINE VINORELBINE-MITOXANTRONE COMBINATION IN METASTATIC BREAST-CANCER PATIENTS RELAPSING AFTER AN ADJUVANT ANTHRACYCLINE REGIMEN - RESULTS OF A PHASE-II STUDY, Oncology, 55(5), 1998, pp. 384-390
Authors:
DELOZIER T
SPIELMANN M
MACELESECH J
JANVIER M
ASSELAIN B
JULIEN JP
WEBER B
MAURIAC L
PETIT JC
KERBRAT P
Citation: T. Delozier et al., SHORT-TERM VS LIFELONG ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER (EBC) - A RANDOMIZED TRIAL (TAM-01), European journal of cancer, 33, 1997, pp. 343-343
Authors:
SPIELMANN M
KALLA S
LLOMBARTCUSSAC A
ESPIE M
NAMER M
FERRERO JM
CUVIER C
FUMOLEAU P
PONZIO A
KAYITALIRE L
POUILLART P
Citation: M. Spielmann et al., ACTIVITY OF GEMCITABINE IN METASTATIC BREAST-CANCER (MBC) PATIENTS PREVIOUSLY TREATED WITH ANTHRACYCLINE-CONTAINING REGIMENS, European journal of cancer, 33, 1997, pp. 663-663
Authors:
KONRAD L
GROOS S
SPIELMANN M
JANSSEN M
AUMULLER G
Citation: L. Konrad et al., DIFFERENTIAL GENE-EXPRESSION DURING TUBULOGENESIS OF THE RAT TESTIS, European journal of cell biology, 72, 1997, pp. 278-278
Authors:
CATIMEL G
SPIELMANN M
DIERAS V
TUBIANAHULIN M
BONNETERRE J
POUILLART P
KAYITALIRE L
GUASTALLA JP
GRAFFAND N
GARET F
DUMORTIER A
PELLAECOSSET B
Citation: G. Catimel et al., PHASE-I STUDIES OF COMBINED PACLITAXEL EPIRUBICIN AND PACLITAXEL/EPIRUBICIN/CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER - THE FRENCH EXPERIENCE/, Seminars in oncology, 24(1), 1997, pp. 8-12
Citation: A. Llombartcussac et al., DOCETAXEL CHEMOTHERAPY INDUCES TRANSVERSE SUPERFICIAL LOSS OF THE NAIL PLATE, Archives of dermatology, 133(11), 1997, pp. 1466-1467
Citation: Jl. Molitor et al., ANGIOSARCOMA OF THE BREAST AFTER CONSERVATIVE SURGERY AND RADIATION-THERAPY FOR BREAST-CARCINOMA - 3 NEW CASES, European journal of cancer, 32A(10), 1996, pp. 1820-1820
Authors:
FIZAZI K
LECESNE A
DOHOLLOU N
AFFAIED S
SPIELMANN M
LECHEVALIER T
Citation: K. Fizazi et al., SERUM NEURON-SPECIFIC ENOLASE (NSE) AS A TUMOR-MARKER FOR THE EWINGS-SARCOMA FAMILY OF TUMORS, European journal of cancer, 32A(10), 1996, pp. 1823-1824
Authors:
CATIMEL G
SPIELMANN M
DIERAS V
KAYITALIRE L
POUILLART P
GUASTALLA JP
SOLERMICHEL P
GRAFFAND N
GARET F
DUMORTIER A
PELLAECOSSET B
CHAZARD M
Citation: G. Catimel et al., PHASE-I STUDY OF PACLITAXEL AND EPIRUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER - A PRELIMINARY-REPORT ON SAFETY, Seminars in oncology, 23(1), 1996, pp. 24-27
Authors:
SMITH I
JONES A
SPIELMANN M
NAMER M
GREEN MD
BONNETERRE J
WANDER HE
HATSCHEK T
WILKING N
ZALCBERG J
SPIERS J
SEYMOUR L
Citation: I. Smith et al., A PHASE-II STUDY IN ADVANCED BREAST-CANCER - ZD1694 (TOMUDEX) A NOVELDIRECT AND SPECIFIC THYMIDYLATE SYNTHASE INHIBITOR, British Journal of Cancer, 74(3), 1996, pp. 479-481
Authors:
SPIELMANN M
CATIMEL G
KAYITALIRE L
POUILLART P
DUMORTIER A
GRAFFAND N
PELLAECOSSET B
Citation: M. Spielmann et al., TAXOL(R) (PACLITAXEL) AND FARMORUBICIN(R) (EPIRUBICIN) IN METASTATIC BREAST-CANCER (MBC) - PRELIMINARY-RESULTS OF A PHASE-I STUDY, European journal of cancer, 31A, 1995, pp. 370-370
Authors:
LECESNE A
VASSAL G
FARACE F
SPIELMANN M
LECHEVALIER T
TURSZ T
ESCUDIER B
Citation: A. Lecesne et al., CONCOMITANT INTERLEUKIN-2-DOXORUBICIN (ADR) SCHEDULE IN PATIENTS (PTS) WITH ADVANCED SOFT-TISSUE SARCOMAS (ASTS) - A PHARMACOKINETIC STUDY, European journal of cancer, 31A, 1995, pp. 586-586
Authors:
LECESNE A
ANTOINE E
SPIELMANN M
LECHEVALIER T
BRAIN E
TOUSSAINT C
JANIN N
KAYITALIRE L
FONTAINE F
GENIN J
VANEL D
CONTESSO G
TURSZ T
Citation: A. Lecesne et al., HIGH-DOSE IFOSFAMIDE - CIRCUMVENTION OF RESISTANCE TO STANDARD-DOSE IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS, Journal of clinical oncology, 13(7), 1995, pp. 1600-1608